Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives

Bedaquiline (BDQ) has demonstrated formidable bactericidal activity towards Mycobacterium tuberculosis (Mtb) in the treatment of multi-drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis (TB). BDQ elicits its therapeutic function by halting the ionic shuttle of Mtb via mycobacterial F1F0 ATP-synthase blockade. However, triple mutations (L59 V, E61D and I66 M) at the ligand-binding cavity characterize emerging BDQ-resistant strains thereby restraining the potentials embedded in this anti-microbial compound, particularly in MDR/XDR-TB therapy. In this report, the effects of these triple mutations on BDQ-Mtb F1F0 ATP-synthase binding were investigated using molecular dynamics, free energy binding and residue interaction network (RIN) analyses. The highlight of our findings is the drastic reduction in BDQ binding affinity (ΔG) in the triple mutant protein, which was caused by a systemic loss in high-affinity interactions primarily mediated by L59, E61 and I66. While wildtype L59 and I66 formed pi-alkyl interactions with BDQ at the F1F0 ATP-synthase binding site, E61 elicited conventional (O--HO) bond. Upon transition, V59 and I66 were devoid of interactions with BDQ while D61 existed in a weaker non-conventional (C--HO) bond. Likewise, these mutations distorted the binding site and overall structural architecture of F1F0 ATP-synthase in the presence of BDQ as revealed by the RIN and conformational analyses. Insights from this study could serve as a starting point for the structure-based design of novel inhibitors that could overcome mutational setbacks posed by BDQ-resistant strains in MDR/XDR-TB treatment.

[1]  M. Soliman,et al.  Characterizing the ligand-binding landscape of Zika NS3 helicase-promising lead compounds as potential inhibitors , 2017 .

[2]  F. Olotu,et al.  Probing Gallate-Mediated Selectivity and High-Affinity Binding of Epigallocatechin Gallate: a Way-Forward in the Design of Selective Inhibitors for Anti-apoptotic Bcl-2 Proteins , 2018, Applied Biochemistry and Biotechnology.

[3]  A. C. Lemos,et al.  Multidrug-resistant tuberculosis , 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[4]  G. Maartens,et al.  Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[5]  K. Andries,et al.  Genetic Basis for Natural and Acquired Resistance to the Diarylquinoline R207910 in Mycobacteria , 2006, Antimicrobial Agents and Chemotherapy.

[6]  M. Soliman,et al.  Synergistic Interplay of The Co-administration of Rifampin And Newly Developed Anti-TB Drug: Could It Be a Promising New Line of TB Therapy? , 2018, Combinatorial chemistry & high throughput screening.

[7]  V. Jarlier,et al.  Synthase C-Ring Structure the Diarylquinoline TMC 207 to the ATP Synthase : New Insights into the Binding of New Mutations in the Mycobacterial ATP , 2012 .

[8]  Shashank Deoghare,et al.  Bedaquiline: A new drug approved for treatment of multidrug-resistant tuberculosis , 2013, Indian journal of pharmacology.

[9]  Kazuhiko Kinosita,et al.  Direct observation of the rotation of F1-ATPase , 1997, Nature.

[10]  A. Diacon,et al.  Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis , 2015, European Respiratory Journal.

[11]  Xiaojie Jin,et al.  Exploring the Molecular Mechanism of Cross-Resistance to HIV-1 Integrase Strand Transfer Inhibitors by Molecular Dynamics Simulation and Residue Interaction Network Analysis , 2013, J. Chem. Inf. Model..

[12]  Roland L. Dunbrack.  Rotamer libraries in the 21st century. , 2002, Current opinion in structural biology.

[13]  Bairong Shen,et al.  The construction of an amino acid network for understanding protein structure and function , 2014, Amino Acids.

[14]  L. Lai,et al.  CH···O Hydrogen Bonds at Protein-Protein Interfaces* 210 , 2002, The Journal of Biological Chemistry.

[15]  M. Soliman,et al.  Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights. , 2018, Future medicinal chemistry.

[16]  Hinrich W. H. Göhlmann,et al.  A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis , 2005, Science.

[17]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[18]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[19]  K. Sharp,et al.  Accurate Calculation of Hydration Free Energies Using Macroscopic Solvent Models , 1994 .

[20]  R. Gennis,et al.  Ionophoric effects of the antitubercular drug bedaquiline , 2018, Proceedings of the National Academy of Sciences.

[21]  Alberto J. M. Martin,et al.  RIP-MD: a tool to study residue interaction networks in protein molecular dynamics , 2018, PeerJ.

[22]  P. Kollman,et al.  Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding , 2000 .

[23]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[24]  K. Persaud,et al.  Effects of point mutations in the binding pocket of the mouse major urinary protein MUP20 on ligand affinity and specificity , 2019, Scientific Reports.

[25]  E. Budianto,et al.  The molecular docking of 1,4-naphthoquinone derivatives as inhibitors of Polo-like kinase 1 using Molegro Virtual Docker - , 2014 .

[26]  D. Case,et al.  Modification of the Generalized Born Model Suitable for Macromolecules , 2000 .

[27]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[28]  J. Walker.  The ATP synthase: the understood, the uncertain and the unknown. , 2013, Biochemical Society transactions.

[29]  Hendrik Sielaff,et al.  Torque generation and elastic power transmission in the rotary FOF1-ATPase , 2009, Nature.

[30]  F. Olotu,et al.  Dynamic perspectives into the mechanisms of mutation‐induced p53‐DNA binding loss and inactivation using active perturbation theory: Structural and molecular insights toward the design of potent reactivators in cancer therapy , 2018, Journal of cellular biochemistry.

[31]  Patrick Polzer,et al.  Structure of the Rotor Ring of F-Type Na+-ATPase from Ilyobacter tartaricus , 2005, Science.

[32]  R. Russell,et al.  Amino‐Acid Properties and Consequences of Substitutions , 2003 .

[33]  Bairong Shen,et al.  Residue interaction network analysis of Dronpa and a DNA clamp. , 2014, Journal of theoretical biology.

[34]  Nadezhda T. Doncheva,et al.  Analyzing and visualizing residue networks of protein structures. , 2011, Trends in biochemical sciences.

[35]  Duncan Poole,et al.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. , 2013, Journal of chemical theory and computation.

[36]  Sheh-Yi Sheu,et al.  Energetics of hydrogen bonds in peptides , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[38]  Holger Gohlke,et al.  MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. , 2012, Journal of chemical theory and computation.

[39]  M. Berney,et al.  Bactericidal mode of action of bedaquiline. , 2015, The Journal of antimicrobial chemotherapy.

[40]  Matteo Aldeghi,et al.  Accurate Estimation of Ligand Binding Affinity Changes upon Protein Mutation , 2018, ACS central science.

[41]  Daniel R Roe,et al.  PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. , 2013, Journal of chemical theory and computation.

[42]  Silvio C. E. Tosatto,et al.  The RING 2.0 web server for high quality residue interaction networks , 2016, Nucleic Acids Res..

[43]  L. Eckhardt-Strelau,et al.  Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline , 2015, Science Advances.

[44]  J. Bayona,et al.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis , 2010, The Lancet.

[45]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[46]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[47]  David S. Goodsell,et al.  A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..

[48]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[49]  P. Boyer.  The ATP synthase--a splendid molecular machine. , 1997, Annual review of biochemistry.

[50]  C. Simmerling,et al.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.

[51]  W. V. van Gunsteren,et al.  A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations , 2001 .

[52]  Mahmoud E. S. Soliman,et al.  Allosteric inhibition abrogates dysregulated LFA-1 activation: Structural insight into mechanisms of diminished immunologic disease , 2018, Comput. Biol. Chem..

[53]  E. Seifert,et al.  OriginPro 9.1: Scientific Data Analysis and Graphing Software - Software Review , 2014, J. Chem. Inf. Model..

[54]  M. Soliman,et al.  Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery , 2016, Journal of biomolecular structure & dynamics.

[55]  Andreas W. Götz,et al.  SPFP: Speed without compromise - A mixed precision model for GPU accelerated molecular dynamics simulations , 2013, Comput. Phys. Commun..